Implementation and Effectiveness of an Intensive Education Program on Phosphate Control Among Hemodialysis Patients: A Non-Randomized, Single-Arm, Single-Center Trial [post]

Jinmei Yin, Jun Yin, Rongli Lian, Peiqiu Li, Jing Zheng
2021 unpublished
Background: Hyperphosphatemia is a common complication in patients on maintenance hemodialysis. Patients' adherence to phosphorus control can be improved by consistent education. However, few studies have focused on the model construction and effects of health education on phosphate control for hemodialysis patients.Objective: To develop an intensive education program focusing on phosphate control among hemodialysis patients and to analyze the effectiveness of this program.Design: A
more » ... sign: A non-randomized, single-arm, single-center trial lasting for 6 months.Setting: This program was conducted in a hemodialysis center in a teaching hospital in Zhuhai, China.Participants: Patients on maintenance hemodialysis with hyperphosphatemia.Methods: A intensive hyperphosphatemia control education program lasting for 6 months was conducted among 366 hemodialysis patients applying the First Principles of Instruction model, which focused on mastering four stages: (a) activation of prior experience, (b) demonstration of skills, (c) application of skills and (d) integration of these skills into real-world activities. The controlled rate of serum phosphorus, knowledge of hyperphosphatemia, and adherence to phosphate binders before and after the education program were assessed. Results: The controlled rate of serum phosphorus was significantly increased from 43.5% to 54.9% (P<0.001). The scores of the patients' knowledge of phosphate control were improved significantly from 59.10±12.90 to 80.98±14.82 (P<0.001). The percentage of high adherence to phosphate binders was increased dramatically from 21.9% to 44.5% (P<0.001). Conclusion: The intensive education program can effectively improve the controlled rate of serum phosphorus, knowledge of hyperphosphatemia, and adherence to phosphate binders among hemodialysis patients.Trial registration: Chinese Clinical Trial Registry, ChiCTR2100042017. Registered 12 January 2021 - Retrospectively registered, http://www.chictr.org.cn/login.aspx
doi:10.21203/rs.3.rs-156687/v1 fatcat:njh6dboy5rekxjpd6fc7pdmaba